Intracellular activation of complement C3 leads to PD-L1 antibody treatment resistance by modulating tumor-associated macrophages
H Zha, X Wang, Y Zhu, D Chen, X Han, F Yang… - Cancer immunology …, 2019 - AACR
Complement aids in the construction of an immunosuppressive tumor microenvironment.
Tumor cell–derived C3 has been previously reported, but whether and how it acts on …
Tumor cell–derived C3 has been previously reported, but whether and how it acts on …
[PDF][PDF] Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages
H Zha, X Wang, Y Zhu, D Chen, X Han, F Yang, J Gao… - researchgate.net
Complement aids in the construction of an immunosuppressive tumor microenvironment.
Tumor cell–derived C3 has been previously reported, but whether and how it acts on …
Tumor cell–derived C3 has been previously reported, but whether and how it acts on …
Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages.
H Zha, X Wang, Y Zhu, D Chen, X Han… - Cancer Immunology …, 2018 - europepmc.org
Complement aids in the construction of an immunosuppressive tumor microenvironment.
Tumor cell-derived C3 has been previously reported, but whether and how it acts on …
Tumor cell-derived C3 has been previously reported, but whether and how it acts on …
Intracellular Activation of Complement C3 Leads to PD-L1 Antibody Treatment Resistance by Modulating Tumor-Associated Macrophages
H Zha, X Wang, Y Zhu, D Chen… - Cancer …, 2019 - pubmed.ncbi.nlm.nih.gov
Complement aids in the construction of an immunosuppressive tumor microenvironment.
Tumor cell-derived C3 has been previously reported, but whether and how it acts on …
Tumor cell-derived C3 has been previously reported, but whether and how it acts on …